Showing results (1-10 of 57) with videos related to
Sort By:
Pageof 6
Frontiers in Bioscience (Landmark Edition)|August 30, 2022
Identification of Gene-Environment Interactions by Non-Parametric Kendall's Partial Correlation with Application to TCGA Ultrahigh-Dimensional Survival Genomic DataJie-Huei Wang, Chun-Ting YangPolymers|April 13, 2019
Investigations on Green Blends Comprising Biodegradable Polymer and Ionic LiquidLi-Ting Lee, Chun-Ting YangPolymers|April 11, 2019
Isothermal and Nonisothermal Crystallization Kinetics of Poly(ε-caprolactone) Blended with a Novel Ionic Liquid, 1-Ethyl-3-propylimidazolium Bis(trifluoromethanesulfonyl)imideChun-Ting Yang, Li-Ting Lee, Tzi-Yi WuJournal of Diabetes Investigation|February 4, 2021
Valuing health states of people with type 2 diabetes: Analyses of the nationwide representative linked databasesShihchen Kuo, Chun-Ting Yang, Hsuan-Ying Chen, et al.Diabetes, Obesity & Metabolism|September 7, 2018
Effects on clinical outcomes of intensifying triple oral antidiabetic drug (OAD) therapy by initiating insulin versus enhancing OAD therapy in patients with type 2 diabetes: A nationwide population-based, propensity-score-matched cohort studyShihchen Kuo, Chun-Ting Yang, Jin-Shang Wu, et al.Diabetes, Obesity & Metabolism|April 4, 2022
Cost-effectiveness of sodium-glucose cotransporter-2 inhibitors versus dipeptidyl peptidase-4 inhibitors among patients with type 2 diabetes with and without established cardiovascular diseases: A model-based simulation analysis using 10-year real-world data and targeted literature reviewZi-Yang Peng, Chun-Ting Yang, Huang-Tz Ou, et al.Diabetes Research and Clinical Practice|March 16, 2023
Value of GLP-1 receptor agonists versus long-acting insulins for type 2 diabetes patients with and without established cardiovascular or chronic kidney diseases: A model-based cost-effectiveness analysis using real-world dataChun-Ting Yang, Wen-Yu Yao, Huang-Tz Ou, et al.Cardiovascular Diabetology|June 15, 2020
Comparative cardiovascular safety of GLP-1 receptor agonists versus other glucose-lowering agents in real-world patients with type 2 diabetes: a nationwide population-based cohort studyChun-Ting Yang, Chen-Yi Yang, Huang-Tz Ou, et al.International Journal of Molecular Sciences|December 23, 2022
A Predictive Pharmacokinetic Model for Immune Cell-Mediated Uptake and Retention of Nanoparticles in TumorsAilton Sousa-Junior, Chun-Ting Yang, Preethi Korangath, et al.Diabetes Care|July 14, 2022
National Trends in the Achievement of Recommended Strategies for Stroke Prevention in U.S. Adults With Type 2 Diabetes, 2001-2018Shihchen Kuo, Chun-Ting Yang, William H Herman, et al.Pageof 6